Maze Therapeutics, Inc. (MAZE)
26.69
-1.19
(-4.27%)
USD |
NASDAQ |
Apr 10, 16:00
26.26
-0.43
(-1.61%)
After-Hours: 20:00
Maze Therapeutics Shareholders Equity (Quarterly) : 354.97M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CDT Equity, Inc. | 4.278M |
| LENZ Therapeutics, Inc. | 284.34M |
| Liminatus Pharma, Inc. | -9.815M |
| Oruka Therapeutics, Inc. | 471.93M |
| MapLight Therapeutics, Inc. | 458.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 397.13M |
| Total Liabilities (Quarterly) | 42.16M |
| Debt to Equity Ratio | 0.0657 |
| Current Ratio | 15.50 |
| Net Debt Paydown Yield | 0.55% |